Bristol-Myers Squibb, like Pfizer and GlaxoSmithKline before it, has entered a strategic collaboration with LSP (Life Sciences Partners), a specialist European healthcare investment firm. "This is the first time BMS is partnering with a European healthcare fund and LSP was chosen after a very rigorous selection process," the VC firm told Scrip.
LSP, which has raised more than €1bn since its inception 25 years ago, has provided start-up and growth capital to...